Drug Approval | December 27, 2021
Lupin receives U.S. FDA approval for Sevelamer Carbonate
This product will be manufactured at Lupin's Goa facility in India
This product will be manufactured at Lupin's Goa facility in India
Pfizer raises production projections from 80 million to 120 million courses of treatment in 2022, as a result of continued investments to support the manufacturing and distribution of Paxlovid
The company is now ready to offer clinical testing anywhere in the world after early case studies conducted in Israel have demonstrated recovery within 48 hours
Saroglitazar Mg is an investigational compound in the USA, and is yet to be approved by the U.S. Food & Drug Administration (USFDA) or European Medicines Agency (EMA)
Arrowhead to receive US $ 120 million upfront payment for Phase 1/2 program for NASH and is eligible to receive potential milestone payments and royalties on commercial sales
The approval is for Cytomegalovirus, a type of Herpes virus
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
U.S. FDA has accepted the investigational new drug application for phase 1 clinical trial in non-Hodgkin’s lymphoma
Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval
UFlex has committed close to US $ 10 million towards various initiatives at its overseas and Indian plants to repurpose plastic waste
Subscribe To Our Newsletter & Stay Updated
